The efficacy and safety of the capecitabine/temozolomide (CAPTEM) regimen in the treatment of well-differentiated neuroendocrine tumors with liver metastasis after failure of previous therapy: Columbia University Medical Center experience.
Paul Eliezer Oberstein
No relevant relationships to disclose
Anthony Paul Gulati
No relevant relationships to disclose
Benjamin A Krantz
No relevant relationships to disclose
Rebecca Anne Moss
No relevant relationships to disclose
Stephen M. Schreibman
No relevant relationships to disclose
Dawn Tsushima
No relevant relationships to disclose
Kelley B Mowatt
No relevant relationships to disclose
John Allendorf
No relevant relationships to disclose
Beth Schrope
No relevant relationships to disclose
James A Lee
No relevant relationships to disclose
William H. Sherman
No relevant relationships to disclose
John A Chabot
No relevant relationships to disclose
Robert Fine
No relevant relationships to disclose